Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Pomerantz LLP is investigating claims on behalf of investors of Amarin Corporation plc (Amarin or the Company) (NASDAQ:AMRN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.


GlobeNewswire Inc | Nov 1, 2021 03:23PM EDT

November 01, 2021

NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amarin Corporation plc (Amarin or the Company) (NASDAQ:AMRN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Amarin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On March 3, 2020, Amarin announced that the United States District Court for the District of Nevadas rul[ed] in favor of the generic companies in the companys patent litigation against two filers of abbreviated new drug applications, or ANDAs, for Amarins VASCEPA (icosapent ethyl) capsule franchise.

On this news, Amarins stock price fell over 70.5% to close at $4.00 per share on March 31, 2020.

Then, on September 3, 2020, following oral argument in the Companys patent litigation, the U.S. Court of Appeals for the Federal Circuit entered an order affirming the District Courts ruling. On this news, Amarins stock price fell over 34.5% to close at $4.30 per share on September 4, 2020. On April 12, 2021, Amarin announced the retirement of John F. Thero as the Companys President and Chief Executive Officer.

On this news, Amarins stock price fell over 14.3% to close at $5.08 per share on April 13, 2021.

Finally, on June 21, 2021, the market learned that the U.S. Supreme Court had rejected Amarins bid to revive its Vascepa patents.

On this news, Amarins stock price fell 8.3% to close at $4.54 per share on June 23, 2021.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

CONTACT:Robert S. WilloughbyPomerantz LLPrswilloughby@pomlaw.com888-476-6529 ext. 7980







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC